Drug Eluting Stent Market Growth By Manufacturers, Type And Application, Forecast To 2026: Biosensors, Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, etc.

According to the current analysis of Reports and Data, the global drug eluting stent market was valued at USD 5.63 Billion in 2018 and is expected to reach USD 8.74 Billion by year 2026, at a CAGR of 5.67 %. The study covers in-depth analysis of drug eluting stents and its extensive use in the cardiovascular diseases. Drug eluting stents are metal stents that are coated with a pharmacologic agent (drug) that is known to suppress restenosis (the reblocking or closing up of an artery after angioplasty due to excess growth inside or at the edge of the stent). Drug eluting stents are usually preferred over bare metal stents for most people. Drug eluting stents are generally to keep the blockage from recurring compared to bare metal stents.

One of the major objectives of drug eluting stents is to limit neointimal hyperplasia. The global drug eluting stent market is propelled by number of factors such as rise in the geriatric population, increasing prevalence of cardiovascular diseases, growing acceptance for minimally invasive endovascular surgeries. However, strict regulatory approval process and lack of skilled professionals are major hindrance for the growth of global drug eluting market during 2019-2026. Conversely, the emerging markets of Asia-Pacific and Latin America are anticipated to provide lucrative growth opportunities to the market players involved in the global drug eluting stent market.

This is the latest report, covering the current COVID-19 scenario. The Coronavirus pandemic has greatly affected every industry worldwide. It has brought along various changes in market conditions. The rapidly changing market scenario and the initial and future assessment of the impact are covered in the research report. The report discusses all the major aspects of the market with expert opinions on the current status along with a historical analysis.

Have Queries? To request a sample or speak to an expert before you buy the report, click on the link below: https://www.reportsanddata.com/sample-enquiry-form/1786

Companies considered and profiled in this market study

Terumo Corporation, Biosensors, Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Biotronik SE & Co. KG, MicroPort Scientific Corporation

For the purpose of this study, Reports and Data have segmented the Drug Eluting Stent Market on the basis of coating, application, end use, and region:

Drug Eluting Stent Market, by Regional Outlook (Revenue in USD Million; 2016–2026)
North America
Europe
Asia Pacific
Middle East & Africa
Latin America

Drug Eluting Stent Market, by Coating (Revenue, USD Million; 2016–2026)
Polymer based coating
Biodegradable
Non-biodegradable
Polymer free coating
Microporous Surface
Microstructured Surface
Slotted Tubular Surface
Nanoporous Surface

Drug Eluting Stent Market, by Application (Revenue, USD Million; 2016–2026)
Coronary Artery Disease
Peripheral Artery Disease

Drug Eluting Stent Market, by End Use (Revenue, USD Million; 2016–2026)
Hospitals
Cardiology Centers
Ambulatory Surgical Centers

Click here to Get customization & check available discount for the report @ https://www.reportsanddata.com/discount-enquiry-form/1786

Further key findings from the report suggest

1. On the basis of applications, coronary artery disease is expected to be the largest segment in the global drug eluting stents because of rise in the circulation of c reactive proteins, binge drinking and smoking

2. There are two major types of polymer-based coatings included in the drug eluting stent market such as biodegradable and non-biodegradable polymer. Microporous surface, microstructured surface, slotted tubular surface, and nanoporous surface are types of polymer free coating

3. Polymer coating can be conformal, inhibiting smooth cell proliferation over the entire surface of the stent, or abluminal, i.e. the release of the drug only has an effect on the surface in contact with the vessel wall

4. There are three key components to a drug eluting stent – the metal stent structure also called the stent platform which is generally made up of surgical stainless steel or a cobalt chromium alloy; these all contain nickel. The polymer which coats the metal stent: this coating contains the drug and delivers(elutes) it to the arterial wall over a period of time. The drug itself which suppresses the formation of excess tissue, sometimes known as “scar tissue”.

5. On the basis of coating, polymer free coating stents segment in the global drug eluting stent market is anticipated to dominate the global drug eluting stents due to higher drug loading capacity of nanoporous surfaces, quicker drug eluting rate. Inflammatory issues caused by the polymers used in stents can be avoided by eliminating the polymer coating completely and releasing the antiproliferative drug directly from the stent surface

6. Drug eluting stents are coated with medication that is slowly released to prevent the growth of scar tissue in the artery lining. Thus, the artery remains smooth, open, ensuring good blood flow.

View Exhaustive Market Research Report @ https://www.reportsanddata.com/report-detail/drug-eluting-stent-market

The report emphasizes the following key questions

Q.1. What are the most lucrative and promising growth prospects for the market?

Q.2. Which sectors are expected to deliver a high growth rate and which industry aspects come into play in this advancement?

Q.3. Which geographies are estimated to exhibit the highest growth and the underlying causes?

Q.4. Which factors are impacting the future of the market and what are the driving factors?

Q.5. What are the hurdles and challenges curtailing the industry’s growth in the forecast period?

Contact Us:

John Watson
Head of Business Development
Reports And Data
40 Wall St. 28th floor New York City, NY 10005 United States
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Reports and Data | Web: www.reportsanddata.com

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

This release was published on openPR.